YK

Yash Kalolia

Active Director Designated Partner DIN 10177603
DIN 10177603 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Yash Kalolia

Data last updated:

Yash Kalolia is a Designated Partner at Shaashvat Pharmaceuticals Llp (since 2023). The company operates in Business Services.

DIN 10177603
Primary Designation Designated Partner
Industry Business Services
First Appointment 26 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 May 20232023Active

Board colleagues of Yash Kalolia

NameDINCompanyDesignation
Ankit Anilkumar Shah10177602Shaashvat Pharmaceuticals LlpDesignated Partner
Pankit Prakash Mehta10177601Shaashvat Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Shaashvat Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Yash Kalolia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yash Kalolia

Yash Kalolia currently holds 1 directorship: Shaashvat Pharmaceuticals Llp (Designated Partner, since 26 May 2023).

Yash Kalolia was first appointed on 26 May 2023 as Designated Partner at Shaashvat Pharmaceuticals Llp.

The current boards of Yash Kalolia's companies include Ankit Anilkumar Shah (Shaashvat Pharmaceuticals Llp), Pankit Prakash Mehta (Shaashvat Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available